Medical Care
Global Oral GLP-1 Market Research Report 2023
- Jan 18, 24
- ID: 2274
- Pages: 71
- Figures: 136
- Views: 45
According to HengCe’s new survey, global Oral GLP-1 market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029.
The main driving factors for oral GLP-1 receptor agonists are the following:
Market demand: As the number of diabetic patients continues to increase around the world, the demand for diabetes treatment drugs is also growing. As a new type of hypoglycemic drug, oral GLP-1 receptor agonists have high efficacy and good safety, so the market demand is also increasing.
Scientific and technological innovation: With the continuous development of biotechnology, scientists have continued to conduct in-depth research on GLP-1 receptor agonists, and have a deeper understanding of their mechanism of action and pharmacological effects. This provides technical support for the development of oral GLP-1 receptor agonists and promotes the development of this field.
Policy support: Government support and encouragement policies for the pharmaceutical industry provide a good environment for the development and marketing of oral GLP-1 receptor agonists. For example, agencies such as the U.S. Food and Drug Administration (FDA) have provided a fast track for the approval of innovative drugs, accelerating the marketing process of oral GLP-1 receptor agonists.
Capital investment: The research and development of oral GLP-1 receptor agonists requires substantial financial support, including clinical trials, production and marketing. Large pharmaceutical companies and venture capital institutions are increasingly investing in the field of oral GLP-1 receptor agonists, providing funding for the development of this field.
Clinical needs: Traditional diabetes treatment drugs have some side effects and limitations. As a new type of hypoglycemic drug, oral GLP-1 receptor agonists have better tolerance and lower side effects and can meet clinical needs. , improve the treatment effect and quality of life of patients.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Oral GLP-1 market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Eli Lilly
Novo Nordisk
Pfizer
AstraZeneca
Sanofi
Segment by Type
Sitagliptin
Saxagliptin
Alagliptin
Others
Segment by Application
Diabetics
Weight Loss People
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Oral GLP-1 report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
The main driving factors for oral GLP-1 receptor agonists are the following:
Market demand: As the number of diabetic patients continues to increase around the world, the demand for diabetes treatment drugs is also growing. As a new type of hypoglycemic drug, oral GLP-1 receptor agonists have high efficacy and good safety, so the market demand is also increasing.
Scientific and technological innovation: With the continuous development of biotechnology, scientists have continued to conduct in-depth research on GLP-1 receptor agonists, and have a deeper understanding of their mechanism of action and pharmacological effects. This provides technical support for the development of oral GLP-1 receptor agonists and promotes the development of this field.
Policy support: Government support and encouragement policies for the pharmaceutical industry provide a good environment for the development and marketing of oral GLP-1 receptor agonists. For example, agencies such as the U.S. Food and Drug Administration (FDA) have provided a fast track for the approval of innovative drugs, accelerating the marketing process of oral GLP-1 receptor agonists.
Capital investment: The research and development of oral GLP-1 receptor agonists requires substantial financial support, including clinical trials, production and marketing. Large pharmaceutical companies and venture capital institutions are increasingly investing in the field of oral GLP-1 receptor agonists, providing funding for the development of this field.
Clinical needs: Traditional diabetes treatment drugs have some side effects and limitations. As a new type of hypoglycemic drug, oral GLP-1 receptor agonists have better tolerance and lower side effects and can meet clinical needs. , improve the treatment effect and quality of life of patients.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Oral GLP-1 market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Eli Lilly
Novo Nordisk
Pfizer
AstraZeneca
Sanofi
Segment by Type
Sitagliptin
Saxagliptin
Alagliptin
Others
Segment by Application
Diabetics
Weight Loss People
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Oral GLP-1 report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral GLP-1 Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Sitagliptin
1.2.3 Saxagliptin
1.2.4 Alagliptin
1.2.5 Others
1.3 Market by Application
1.3.1 Global Oral GLP-1 Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Diabetics
1.3.3 Weight Loss People
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral GLP-1 Market Perspective (2018-2029)
2.2 Oral GLP-1 Growth Trends by Region
2.2.1 Global Oral GLP-1 Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Oral GLP-1 Historic Market Size by Region (2018-2023)
2.2.3 Oral GLP-1 Forecasted Market Size by Region (2024-2029)
2.3 Oral GLP-1 Market Dynamics
2.3.1 Oral GLP-1 Industry Trends
2.3.2 Oral GLP-1 Market Drivers
2.3.3 Oral GLP-1 Market Challenges
2.3.4 Oral GLP-1 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral GLP-1 Players by Revenue
3.1.1 Global Top Oral GLP-1 Players by Revenue (2018-2023)
3.1.2 Global Oral GLP-1 Revenue Market Share by Players (2018-2023)
3.2 Global Oral GLP-1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oral GLP-1 Revenue
3.4 Global Oral GLP-1 Market Concentration Ratio
3.4.1 Global Oral GLP-1 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral GLP-1 Revenue in 2022
3.5 Oral GLP-1 Key Players Head office and Area Served
3.6 Key Players Oral GLP-1 Product Solution and Service
3.7 Date of Enter into Oral GLP-1 Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral GLP-1 Breakdown Data by Type
4.1 Global Oral GLP-1 Historic Market Size by Type (2018-2023)
4.2 Global Oral GLP-1 Forecasted Market Size by Type (2024-2029)
5 Oral GLP-1 Breakdown Data by Application
5.1 Global Oral GLP-1 Historic Market Size by Application (2018-2023)
5.2 Global Oral GLP-1 Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Oral GLP-1 Market Size (2018-2029)
6.2 North America Oral GLP-1 Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Oral GLP-1 Market Size by Country (2018-2023)
6.4 North America Oral GLP-1 Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oral GLP-1 Market Size (2018-2029)
7.2 Europe Oral GLP-1 Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Oral GLP-1 Market Size by Country (2018-2023)
7.4 Europe Oral GLP-1 Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral GLP-1 Market Size (2018-2029)
8.2 Asia-Pacific Oral GLP-1 Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Oral GLP-1 Market Size by Region (2018-2023)
8.4 Asia-Pacific Oral GLP-1 Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oral GLP-1 Market Size (2018-2029)
9.2 Latin America Oral GLP-1 Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Oral GLP-1 Market Size by Country (2018-2023)
9.4 Latin America Oral GLP-1 Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral GLP-1 Market Size (2018-2029)
10.2 Middle East & Africa Oral GLP-1 Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Oral GLP-1 Market Size by Country (2018-2023)
10.4 Middle East & Africa Oral GLP-1 Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Oral GLP-1 Introduction
11.1.4 Eli Lilly Revenue in Oral GLP-1 Business (2018-2023)
11.1.5 Eli Lilly Recent Development
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Detail
11.2.2 Novo Nordisk Business Overview
11.2.3 Novo Nordisk Oral GLP-1 Introduction
11.2.4 Novo Nordisk Revenue in Oral GLP-1 Business (2018-2023)
11.2.5 Novo Nordisk Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Oral GLP-1 Introduction
11.3.4 Pfizer Revenue in Oral GLP-1 Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Detail
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Oral GLP-1 Introduction
11.4.4 AstraZeneca Revenue in Oral GLP-1 Business (2018-2023)
11.4.5 AstraZeneca Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Oral GLP-1 Introduction
11.5.4 Sanofi Revenue in Oral GLP-1 Business (2018-2023)
11.5.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral GLP-1 Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Sitagliptin
1.2.3 Saxagliptin
1.2.4 Alagliptin
1.2.5 Others
1.3 Market by Application
1.3.1 Global Oral GLP-1 Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Diabetics
1.3.3 Weight Loss People
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral GLP-1 Market Perspective (2018-2029)
2.2 Oral GLP-1 Growth Trends by Region
2.2.1 Global Oral GLP-1 Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Oral GLP-1 Historic Market Size by Region (2018-2023)
2.2.3 Oral GLP-1 Forecasted Market Size by Region (2024-2029)
2.3 Oral GLP-1 Market Dynamics
2.3.1 Oral GLP-1 Industry Trends
2.3.2 Oral GLP-1 Market Drivers
2.3.3 Oral GLP-1 Market Challenges
2.3.4 Oral GLP-1 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral GLP-1 Players by Revenue
3.1.1 Global Top Oral GLP-1 Players by Revenue (2018-2023)
3.1.2 Global Oral GLP-1 Revenue Market Share by Players (2018-2023)
3.2 Global Oral GLP-1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oral GLP-1 Revenue
3.4 Global Oral GLP-1 Market Concentration Ratio
3.4.1 Global Oral GLP-1 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral GLP-1 Revenue in 2022
3.5 Oral GLP-1 Key Players Head office and Area Served
3.6 Key Players Oral GLP-1 Product Solution and Service
3.7 Date of Enter into Oral GLP-1 Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral GLP-1 Breakdown Data by Type
4.1 Global Oral GLP-1 Historic Market Size by Type (2018-2023)
4.2 Global Oral GLP-1 Forecasted Market Size by Type (2024-2029)
5 Oral GLP-1 Breakdown Data by Application
5.1 Global Oral GLP-1 Historic Market Size by Application (2018-2023)
5.2 Global Oral GLP-1 Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Oral GLP-1 Market Size (2018-2029)
6.2 North America Oral GLP-1 Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Oral GLP-1 Market Size by Country (2018-2023)
6.4 North America Oral GLP-1 Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oral GLP-1 Market Size (2018-2029)
7.2 Europe Oral GLP-1 Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Oral GLP-1 Market Size by Country (2018-2023)
7.4 Europe Oral GLP-1 Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral GLP-1 Market Size (2018-2029)
8.2 Asia-Pacific Oral GLP-1 Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Oral GLP-1 Market Size by Region (2018-2023)
8.4 Asia-Pacific Oral GLP-1 Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oral GLP-1 Market Size (2018-2029)
9.2 Latin America Oral GLP-1 Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Oral GLP-1 Market Size by Country (2018-2023)
9.4 Latin America Oral GLP-1 Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral GLP-1 Market Size (2018-2029)
10.2 Middle East & Africa Oral GLP-1 Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Oral GLP-1 Market Size by Country (2018-2023)
10.4 Middle East & Africa Oral GLP-1 Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Oral GLP-1 Introduction
11.1.4 Eli Lilly Revenue in Oral GLP-1 Business (2018-2023)
11.1.5 Eli Lilly Recent Development
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Detail
11.2.2 Novo Nordisk Business Overview
11.2.3 Novo Nordisk Oral GLP-1 Introduction
11.2.4 Novo Nordisk Revenue in Oral GLP-1 Business (2018-2023)
11.2.5 Novo Nordisk Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Oral GLP-1 Introduction
11.3.4 Pfizer Revenue in Oral GLP-1 Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Detail
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Oral GLP-1 Introduction
11.4.4 AstraZeneca Revenue in Oral GLP-1 Business (2018-2023)
11.4.5 AstraZeneca Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Oral GLP-1 Introduction
11.5.4 Sanofi Revenue in Oral GLP-1 Business (2018-2023)
11.5.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Oral GLP-1 Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Sitagliptin
Table 3. Key Players of Saxagliptin
Table 4. Key Players of Alagliptin
Table 5. Key Players of Others
Table 6. Global Oral GLP-1 Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Oral GLP-1 Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Oral GLP-1 Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Oral GLP-1 Market Share by Region (2018-2023)
Table 10. Global Oral GLP-1 Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Oral GLP-1 Market Share by Region (2024-2029)
Table 12. Oral GLP-1 Market Trends
Table 13. Oral GLP-1 Market Drivers
Table 14. Oral GLP-1 Market Challenges
Table 15. Oral GLP-1 Market Restraints
Table 16. Global Oral GLP-1 Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Oral GLP-1 Market Share by Players (2018-2023)
Table 18. Global Top Oral GLP-1 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral GLP-1 as of 2022)
Table 19. Ranking of Global Top Oral GLP-1 Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Oral GLP-1 Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Oral GLP-1 Product Solution and Service
Table 23. Date of Enter into Oral GLP-1 Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Oral GLP-1 Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Oral GLP-1 Revenue Market Share by Type (2018-2023)
Table 27. Global Oral GLP-1 Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Oral GLP-1 Revenue Market Share by Type (2024-2029)
Table 29. Global Oral GLP-1 Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Oral GLP-1 Revenue Market Share by Application (2018-2023)
Table 31. Global Oral GLP-1 Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Oral GLP-1 Revenue Market Share by Application (2024-2029)
Table 33. North America Oral GLP-1 Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Oral GLP-1 Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Oral GLP-1 Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Oral GLP-1 Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Oral GLP-1 Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Oral GLP-1 Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Oral GLP-1 Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Oral GLP-1 Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Oral GLP-1 Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Oral GLP-1 Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Oral GLP-1 Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Oral GLP-1 Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Oral GLP-1 Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Oral GLP-1 Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Oral GLP-1 Market Size by Country (2024-2029) & (US$ Million)
Table 48. Eli Lilly Company Detail
Table 49. Eli Lilly Business Overview
Table 50. Eli Lilly Oral GLP-1 Product
Table 51. Eli Lilly Revenue in Oral GLP-1 Business (2018-2023) & (US$ Million)
Table 52. Eli Lilly Recent Development
Table 53. Novo Nordisk Company Detail
Table 54. Novo Nordisk Business Overview
Table 55. Novo Nordisk Oral GLP-1 Product
Table 56. Novo Nordisk Revenue in Oral GLP-1 Business (2018-2023) & (US$ Million)
Table 57. Novo Nordisk Recent Development
Table 58. Pfizer Company Detail
Table 59. Pfizer Business Overview
Table 60. Pfizer Oral GLP-1 Product
Table 61. Pfizer Revenue in Oral GLP-1 Business (2018-2023) & (US$ Million)
Table 62. Pfizer Recent Development
Table 63. AstraZeneca Company Detail
Table 64. AstraZeneca Business Overview
Table 65. AstraZeneca Oral GLP-1 Product
Table 66. AstraZeneca Revenue in Oral GLP-1 Business (2018-2023) & (US$ Million)
Table 67. AstraZeneca Recent Development
Table 68. Sanofi Company Detail
Table 69. Sanofi Business Overview
Table 70. Sanofi Oral GLP-1 Product
Table 71. Sanofi Revenue in Oral GLP-1 Business (2018-2023) & (US$ Million)
Table 72. Sanofi Recent Development
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral GLP-1 Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Oral GLP-1 Market Share by Type: 2022 VS 2029
Figure 3. Sitagliptin Features
Figure 4. Saxagliptin Features
Figure 5. Alagliptin Features
Figure 6. Others Features
Figure 7. Global Oral GLP-1 Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Oral GLP-1 Market Share by Application: 2022 VS 2029
Figure 9. Diabetics Case Studies
Figure 10. Weight Loss People Case Studies
Figure 11. Others Case Studies
Figure 12. Oral GLP-1 Report Years Considered
Figure 13. Global Oral GLP-1 Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Oral GLP-1 Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Oral GLP-1 Market Share by Region: 2022 VS 2029
Figure 16. Global Oral GLP-1 Market Share by Players in 2022
Figure 17. Global Top Oral GLP-1 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral GLP-1 as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Oral GLP-1 Revenue in 2022
Figure 19. North America Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Oral GLP-1 Market Share by Country (2018-2029)
Figure 21. United States Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Oral GLP-1 Market Share by Country (2018-2029)
Figure 25. Germany Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Oral GLP-1 Market Share by Region (2018-2029)
Figure 33. China Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Oral GLP-1 Market Share by Country (2018-2029)
Figure 41. Mexico Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Oral GLP-1 Market Share by Country (2018-2029)
Figure 45. Turkey Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Eli Lilly Revenue Growth Rate in Oral GLP-1 Business (2018-2023)
Figure 48. Novo Nordisk Revenue Growth Rate in Oral GLP-1 Business (2018-2023)
Figure 49. Pfizer Revenue Growth Rate in Oral GLP-1 Business (2018-2023)
Figure 50. AstraZeneca Revenue Growth Rate in Oral GLP-1 Business (2018-2023)
Figure 51. Sanofi Revenue Growth Rate in Oral GLP-1 Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Table 1. Global Oral GLP-1 Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Sitagliptin
Table 3. Key Players of Saxagliptin
Table 4. Key Players of Alagliptin
Table 5. Key Players of Others
Table 6. Global Oral GLP-1 Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Oral GLP-1 Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Oral GLP-1 Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Oral GLP-1 Market Share by Region (2018-2023)
Table 10. Global Oral GLP-1 Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Oral GLP-1 Market Share by Region (2024-2029)
Table 12. Oral GLP-1 Market Trends
Table 13. Oral GLP-1 Market Drivers
Table 14. Oral GLP-1 Market Challenges
Table 15. Oral GLP-1 Market Restraints
Table 16. Global Oral GLP-1 Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Oral GLP-1 Market Share by Players (2018-2023)
Table 18. Global Top Oral GLP-1 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral GLP-1 as of 2022)
Table 19. Ranking of Global Top Oral GLP-1 Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Oral GLP-1 Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Oral GLP-1 Product Solution and Service
Table 23. Date of Enter into Oral GLP-1 Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Oral GLP-1 Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Oral GLP-1 Revenue Market Share by Type (2018-2023)
Table 27. Global Oral GLP-1 Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Oral GLP-1 Revenue Market Share by Type (2024-2029)
Table 29. Global Oral GLP-1 Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Oral GLP-1 Revenue Market Share by Application (2018-2023)
Table 31. Global Oral GLP-1 Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Oral GLP-1 Revenue Market Share by Application (2024-2029)
Table 33. North America Oral GLP-1 Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Oral GLP-1 Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Oral GLP-1 Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Oral GLP-1 Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Oral GLP-1 Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Oral GLP-1 Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Oral GLP-1 Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Oral GLP-1 Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Oral GLP-1 Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Oral GLP-1 Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Oral GLP-1 Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Oral GLP-1 Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Oral GLP-1 Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Oral GLP-1 Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Oral GLP-1 Market Size by Country (2024-2029) & (US$ Million)
Table 48. Eli Lilly Company Detail
Table 49. Eli Lilly Business Overview
Table 50. Eli Lilly Oral GLP-1 Product
Table 51. Eli Lilly Revenue in Oral GLP-1 Business (2018-2023) & (US$ Million)
Table 52. Eli Lilly Recent Development
Table 53. Novo Nordisk Company Detail
Table 54. Novo Nordisk Business Overview
Table 55. Novo Nordisk Oral GLP-1 Product
Table 56. Novo Nordisk Revenue in Oral GLP-1 Business (2018-2023) & (US$ Million)
Table 57. Novo Nordisk Recent Development
Table 58. Pfizer Company Detail
Table 59. Pfizer Business Overview
Table 60. Pfizer Oral GLP-1 Product
Table 61. Pfizer Revenue in Oral GLP-1 Business (2018-2023) & (US$ Million)
Table 62. Pfizer Recent Development
Table 63. AstraZeneca Company Detail
Table 64. AstraZeneca Business Overview
Table 65. AstraZeneca Oral GLP-1 Product
Table 66. AstraZeneca Revenue in Oral GLP-1 Business (2018-2023) & (US$ Million)
Table 67. AstraZeneca Recent Development
Table 68. Sanofi Company Detail
Table 69. Sanofi Business Overview
Table 70. Sanofi Oral GLP-1 Product
Table 71. Sanofi Revenue in Oral GLP-1 Business (2018-2023) & (US$ Million)
Table 72. Sanofi Recent Development
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral GLP-1 Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Oral GLP-1 Market Share by Type: 2022 VS 2029
Figure 3. Sitagliptin Features
Figure 4. Saxagliptin Features
Figure 5. Alagliptin Features
Figure 6. Others Features
Figure 7. Global Oral GLP-1 Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Oral GLP-1 Market Share by Application: 2022 VS 2029
Figure 9. Diabetics Case Studies
Figure 10. Weight Loss People Case Studies
Figure 11. Others Case Studies
Figure 12. Oral GLP-1 Report Years Considered
Figure 13. Global Oral GLP-1 Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Oral GLP-1 Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Oral GLP-1 Market Share by Region: 2022 VS 2029
Figure 16. Global Oral GLP-1 Market Share by Players in 2022
Figure 17. Global Top Oral GLP-1 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral GLP-1 as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Oral GLP-1 Revenue in 2022
Figure 19. North America Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Oral GLP-1 Market Share by Country (2018-2029)
Figure 21. United States Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Oral GLP-1 Market Share by Country (2018-2029)
Figure 25. Germany Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Oral GLP-1 Market Share by Region (2018-2029)
Figure 33. China Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Oral GLP-1 Market Share by Country (2018-2029)
Figure 41. Mexico Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Oral GLP-1 Market Share by Country (2018-2029)
Figure 45. Turkey Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Oral GLP-1 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Eli Lilly Revenue Growth Rate in Oral GLP-1 Business (2018-2023)
Figure 48. Novo Nordisk Revenue Growth Rate in Oral GLP-1 Business (2018-2023)
Figure 49. Pfizer Revenue Growth Rate in Oral GLP-1 Business (2018-2023)
Figure 50. AstraZeneca Revenue Growth Rate in Oral GLP-1 Business (2018-2023)
Figure 51. Sanofi Revenue Growth Rate in Oral GLP-1 Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232